尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Haydon William David, 首席执行官. Director active across 1 company, notably Avanos Medical, INC.. Cumulatively, 2 disclosures have been logged. Activity tracked since 4 March 2022. The latest transaction was disclosed on 6 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Haydon William David is Senior Vice President, General Manager of the Pain Franchise at AVANOS MEDICAL, INC. He is responsible for the strategy and operations of the pain franchise, aiming to improve patient outcomes.